CRP and systemic lupus erythematosus: Aberrant type I interferon responses constitute a pathogenic hallmark of SLE and are usually associated with antiviral-like low-CRP responses [34], possibly suggesting that additional inflammatory pathways are overactivated in patients with SLE who develop myocarditis.